$6.75
Price
$364M
Market Cap
—
P/E Ratio
-8.4
Forward P/E
$-0.72
EPS (TTM)
—
Dividend Yield
$44M
Cash
$240000
Total Debt
54M
Shares Out
$5.14
$10.42
52-Week Range
Institutional Ownership of Diamedica Therapeutics Inc
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| 3.5M | $24M | $4.89 | +38.13% |
Trading Activity for Diamedica Therapeutics Inc
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q2 | |||||
| BUY | +70.8% | 3.5M | $24M | $6.18 | |
| 2025-Q4 | |||||
| SELL | -38.2% | 2.0M | $16M | $7.05 | |
| 2025-Q3 | |||||
| BUY | +98.2% | 3.3M | $18M | $5.32 | |
| 2025-Q2 | |||||
| BUY | +1.5% | 1.6M | $6M | $3.96 | |
| 2024-Q4 | |||||
| BUY | +7.5% | 1.6M | $9M | $4.42 | |
| 2024-Q3 | |||||
| BUY | +8.0% | 1.5M | $6M | $3.64 | |
| 2024-Q2 | |||||
| BUY | +58.4% | 1.4M | $4M | $2.73 | |
| 2023-Q4 | |||||
| BUY | +0.9% | 883.6K | $3M | $2.46 | |
| 2023-Q3 | |||||
| BUY | +7.8% | 876.0K | $2M | $3.09 | |
| 2023-Q2 | |||||
| BUY | +170.8% | 812.5K | $1M | $1.77 | |
| 2021-Q4 | |||||
| BUY | +50.0% | 300.0K | $1M | $3.94 | |
| 2021-Q3 | |||||
| BUY | +300.0% | 200.0K | $802000 | $3.88 | |
| 2021-Q1 | |||||
| BUY | +66.7% | 50.0K | $458000 | $9.40 | |
| 2020-Q4 | |||||
| BUY | NEW | 30.0K | $304000 | $4.60 | |
Insider Trading for Diamedica Therapeutics Inc
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.